The APRN's complete guide to prescribing drug therapy 2017 /

Saved in:
Bibliographic Details
Main Author: Wirfs, Mari J. (Author)
Format: eBook
Published: New York, NY : Springer Publishing Company, LLC, [2017]
Online Access:CONNECT
LEADER 05663cam a2200625Ii 4500
001 mig00005471548
006 m o d
007 cr cnu---unuuu
008 160831s2017 nyu of 001 0 eng d
005 20220721163758.6
035 0 0 |a ocm00000001wrldshrocn957558066 
035 |a 1WRLDSHRocn957558066 
040 |a N$T  |b eng  |e rda  |e pn  |c N$T  |d IDEBK  |d N$T  |d YDX  |d OCLCF  |d TEFOD  |d OCLCO  |d OCLCQ  |d OCLCA  |d AGLDB  |d SNK  |d DKU  |d AUW  |d INTCL  |d MHW  |d BTN  |d IGB  |d D6H  |d VTS  |d AU@  |d OCLCO  |d G3B  |d OCLCO  |d OCLCA  |d S8J  |d S9I  |d STF  |d GWM  |d OCLCO 
019 |a 960999940  |a 961202198 
020 |a 9780826166678  |q (electronic bk.) 
020 |a 0826166679  |q (electronic bk.) 
020 |z 9780826166661 
020 |z 0826166660 
035 |a (OCoLC)957558066  |z (OCoLC)960999940  |z (OCoLC)961202198 
037 |a 25FBAAB6-E27D-4513-BDA5-1E3FBBBE1945  |b OverDrive, Inc.  |n 
050 4 |a RM301 
060 1 4 |a WY 49 
082 0 4 |a 615.1  |2 23 
049 |a TXMM 
100 1 |a Wirfs, Mari J.,  |e author. 
245 1 4 |a The APRN's complete guide to prescribing drug therapy 2017 /  |c Mari J. Wirfs. 
264 1 |a New York, NY :  |b Springer Publishing Company, LLC,  |c [2017] 
300 |a 1 online resource (pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file  |2 rda 
500 |a Includes index. 
588 0 |a Online resource; title from PDF title page (EBSCO, viewed September 12, 2016). 
505 0 |a Cover; Title; Copyright; Contents; Reviewers; Abbreviations; Preface; Acknowledgments; Share The APRN's Complete Guide to Prescribing Drug Therapy 2017; Section I: Drug Therapy by Clinical Diagnosis; Acetaminophen Overdose; Antidote/Chelating Agent; Acne Rosacea; Topical Alpha-2 Agonist; Topical Antimicrobials; Oral Antimicrobials; Acne Vulgaris; Antibacterial Soaps; Topical Antimicrobials; Oral Antimicrobials; Topical Retinoids; Topical Retinoid/Antimicrobial Combinations; Oral Retinoid; Oral Contraceptives; Acromegaly; Growth Hormone Receptor Antagonist; Actinic Keratosis 
505 8 |a Alcohol Dependence/Alcohol Withdrawal SyndromeAlcohol Withdrawal Syndrome; Abstinence Therapy; Aversion Therapy; Allergic Reaction: General; Parenteral Antihistamine; Alzheimer's Disease; Nutritional Supplement; Reversible Anticholinesterase Inhibitors (RAIs); N-Methyl-D-Aspartate (NMDA) Receptor Antagonist; N-Methyl-D-Aspartate (NMDA) Receptor Antagonist/Acetylcholin-Esterase Inhibitor Combination; Ergot Alkaloid (Dopamine Agonist); Amebiasis; Amebiasis (Intestinal); Amebiasis (Extraintestinal); Amebic Liver Abscess; Anti-Infectives; Amenorrhea: Secondary; Anaphylaxis 
505 8 |a Anaphylaxis Emergency Treatment KitsAnemia of Chronic Kidney Disease (CKD) and Chronic Renal Failure (CRF); Erythropoiesis Stimulating Agents (ESAs); Erythropoietin Human, Recombinant; Anemia: Folic Acid Deficiency; Anemia: Iron Deficiency; Iron Preparations; Anemia: Megaloblastic/Anemia: Pernicious; Angina Pectoris: Stable; Calcium Antagonists; Beta-Blockers; Nitrates; Non-Nitrate Peripheral Vasodilator; Nitrate/Peripheral Vasodilator Combination; Non-Nitrate Anti-Anginal; Anorexia/Cachexia; Appetite Stimulants; Anthrax (Bacillus Anthracis) 
505 8 |a Postexposure Prophylaxis of Inhalational Anthrax and Treatment of Inhaled and Cutaneous Anthrax InfectionImmune Globulin; Treatment of Inhalational, GI, and Oropharyngeal Anthrax; Anxiety Disorder: Generalized (GAD)/Anxiety Disorder: Social (SAD); 1st Generation Antihistamine; Azaspirones; Benzodiazepines; Tricyclic Antidepressants (TCAs); Phenothiazines; Selective Serotonin Reuptake Inhibitors (SSRIs); Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs); Combination Agents; Aphthous Stomatitis (Mouth Ulcer, Canker Sore); Anti-Inflammatory Agents; Topical Anesthetics 
505 8 |a Debriding Agent/CleanserAnti-Infectives; Aspergillosis (Scedosporium Apiospermum, Fusarium SPP.); Invasive Infection; Asthma; Leukotriene Receptor Antagonists (LRAs); IGE Blocker (IGG1K Monoclonal Antibody); Inhaled Anticholinergics; Inhaled Corticosteroids; Inhaled Mast Cell Stabilizers (Prophylaxis); Inhaled Beta Agonists (Bronchodilators); Inhaled Racepinephrine (Bronchodilator); Inhaled Long-Acting Anticholinergic; Inhaled Anticholinergic/Beta Agonist; Inhaled Beta Agonist (Long-Acting) (LABA); Corticosteroid/Inhaled Long-Acting Beta Agonist (LABA); Oral Beta2-Agonists (Bronchodilators) 
590 |a EBSCO eBook Clinical Collection 
590 |a EBSCO eBook Academic Comprehensive Collection North America 
650 0 |a Drugs  |v Handbooks, manuals, etc. 
655 2 |a Handbook 
655 7 |a Handbooks and manuals.  |2 fast  |0 (OCoLC)fst01423877 
655 7 |a Handbooks and manuals.  |2 lcgft 
655 7 |a Guides et manuels.  |2 rvmgf 
776 0 8 |i Print version:  |a Wirfs, Mari J.  |t APRN's complete guide to prescribing drug therapy 2017.  |d New York, NY : Springer Publishing Company, LLC, [2017]  |z 9780826166661  |w (DLC) 2016013691  |w (OCoLC)945566006 
856 4 0 |u  |z CONNECT  |3 eBooks on EBSCOhost  |t 0 
949 |a ho0 
994 |a 92  |b TXM 
998 |a wi  |d z 
999 f f |s 71f44891-cab4-4456-92c1-9208c0de26e0  |i dd1454db-e626-4cc1-adbc-1c4096d702dc  |t 0 
952 f f |a Middle Tennessee State University  |b Main  |c James E. Walker Library  |d Electronic Resources  |t 1  |e RM301   |h Library of Congress classification 
856 4 0 |3 eBooks on EBSCOhost  |t 0  |u  |z CONNECT